Anxiety and Depression

  • Vincent S. FanEmail author
  • Nicholas D. Giardino
Part of the Respiratory Medicine book series (RM)


Increasing evidence suggests that depression and anxiety are important comorbidities in COPD, and are associated with a number of adverse outcomes including worse health-related quality of life, an increased risk of exacerbations, and a higher mortality. The burden of depression in COPD is higher than in the general population, and many patients remain undiagnosed. Although treatment of depression and anxiety may include medications or pharmacotherapy, many patients with depressive symptoms do not receive treatment.


Depression Anxiety COPD Comorbidity Quality of life Exacerbation Mortality Diagnosis Medication Pharmacotherapy Treatment 


  1. 1.
    Engstrom CP, Persson LO, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax. 1996;51(8):825–30.PubMedGoogle Scholar
  2. 2.
    Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.PubMedGoogle Scholar
  3. 3.
    Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21(2):80–6.PubMedGoogle Scholar
  4. 4.
    Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–7.PubMedGoogle Scholar
  5. 5.
    Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–7.PubMedGoogle Scholar
  6. 6.
    van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–92.PubMedGoogle Scholar
  7. 7.
    Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J. 2005;26(2):242–8.PubMedGoogle Scholar
  8. 8.
    Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–S56.PubMedGoogle Scholar
  9. 9.
    Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor ­structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179:540–4.PubMedGoogle Scholar
  10. 10.
    Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.PubMedGoogle Scholar
  11. 11.
    Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008;23(11):1757–62.PubMedGoogle Scholar
  12. 12.
    Yohannes AM, Roomi J, Baldwin RC, Connolly MJ. Depression in elderly outpatients with disabling chronic obstructive pulmonary disease. Age Ageing. 1998;27(2):155–60.PubMedGoogle Scholar
  13. 13.
    Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–74.PubMedGoogle Scholar
  14. 14.
    van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412–6.PubMedGoogle Scholar
  15. 15.
    Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177(7):743–51.PubMedGoogle Scholar
  16. 16.
    Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93.PubMedGoogle Scholar
  17. 17.
    Lewis KE, Annandale JA, Sykes RN, Hurlin C, Owen C, Harrison NK. Prevalence of anxiety and depression in patients with severe COPD: similar high levels with and without LTOT. COPD. 2007;4(4):305–12.PubMedGoogle Scholar
  18. 18.
    Koenig HG. Differences between depressed patients with heart failure and those with pulmonary disease. Am J Geriatr Psychiatry. 2006;14(3):211–9.PubMedGoogle Scholar
  19. 19.
    Katz P, Julian L, Omachi TA, et al. The impact of disability on depression among individuals with COPD. Chest. 2009;137(4):838–45.PubMedGoogle Scholar
  20. 20.
    Cullen DL, Stiffler D. Long-term oxygen therapy: review from the patients’ perspective. Chron Respir Dis. 2009;6(3):141–7.PubMedGoogle Scholar
  21. 21.
    Daeppen JB, Smith TL, Danko GP, et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism. Alcohol Alcohol. 2000;35(2):171–5.PubMedGoogle Scholar
  22. 22.
    Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165(11):1260–6.PubMedGoogle Scholar
  23. 23.
    Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010;137(2):341–7.PubMedGoogle Scholar
  24. 24.
    van den Bemt L, Schermer T, Bor H, et al. The risk for depression comorbidity in patients with COPD. Chest. 2009;135(1):108–14.PubMedGoogle Scholar
  25. 25.
    Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2009;25(12):1209–21.Google Scholar
  26. 26.
    Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–34.PubMedGoogle Scholar
  27. 27.
    Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–55.Google Scholar
  28. 28.
    Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119(10 Suppl 1):21–31.PubMedGoogle Scholar
  29. 29.
    Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med. 2009;103(10):1572–9.PubMedGoogle Scholar
  30. 30.
    Giardino ND, Curtis JL, Andrei AC, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010;11:29.PubMedGoogle Scholar
  31. 31.
    Chavannes NH, Huibers MJ, Schermer TR, et al. Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract. 2005;22(6):604–7.PubMedGoogle Scholar
  32. 32.
    Kuhl K, Schurmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis. 2008;3(4):727–36.PubMedGoogle Scholar
  33. 33.
    Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med. 1998;92(10):1231–6.PubMedGoogle Scholar
  34. 34.
    Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47(4):312–9.PubMedGoogle Scholar
  35. 35.
    Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23(2):56–61.PubMedGoogle Scholar
  36. 36.
    Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–71.PubMedGoogle Scholar
  37. 37.
    Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122(8):778.PubMedGoogle Scholar
  38. 38.
    Wall MP. Predictors of functional performance in community-dwelling people with COPD. J Nurs Scholarsh. 2007;39(3):222–8.PubMedGoogle Scholar
  39. 39.
    Weaver TE, Narsavage GL. Physiological and psychological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res. 1992;41(5):286–91.PubMedGoogle Scholar
  40. 40.
    Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86(9):1788–92.PubMedGoogle Scholar
  41. 41.
    Yeh ML, Chen HH, Liao YC, Liao WY. Testing the functional status model in patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004;48(4):342–50.PubMedGoogle Scholar
  42. 42.
    Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587–96.PubMedGoogle Scholar
  43. 43.
    Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159(19):2349–56.PubMedGoogle Scholar
  44. 44.
    Penninx BW, Deeg DJ, van Eijk JT, Beekman AT, Guralnik JM. Changes in depression and physical decline in older adults: a longitudinal perspective. J Affect Disord. 2000;61(1–2):1–12.PubMedGoogle Scholar
  45. 45.
    Skotzko CE, Krichten C, Zietowski G, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail. 2000;6(4):300–5.PubMedGoogle Scholar
  46. 46.
    Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33(2):190–201.PubMedGoogle Scholar
  47. 47.
    Eiser N, Harte R, Spiros K, Phillips C, Isaac MT. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD. 2005;2(2):233–41.PubMedGoogle Scholar
  48. 48.
    Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol. 2005;96(9):1179–85.PubMedGoogle Scholar
  49. 49.
    Lin EH, Heckbert SR, Rutter CM, et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7(5):414–21.PubMedGoogle Scholar
  50. 50.
    Mendes de Leon CF. Depression and social support in recovery from myocardial infarction: confounding and confusion. Psychosom Med. 1999;61(6):738–9.PubMedGoogle Scholar
  51. 51.
    Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441–8.PubMedGoogle Scholar
  52. 52.
    de Voogd JN, Wempe JB, Koeter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619–25.PubMedGoogle Scholar
  53. 53.
    Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(21):2345–53.PubMedGoogle Scholar
  54. 54.
    Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–20.PubMedGoogle Scholar
  55. 55.
    Yohannes AM. Depression and COPD in older people: a review and discussion. Br J Community Nurs. 2005;10(1):42–6.PubMedGoogle Scholar
  56. 56.
    Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing. 2002;31(2):137–40.PubMedGoogle Scholar
  57. 57.
    Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 2001;57(1–3):141–52.PubMedGoogle Scholar
  58. 58.
    Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des. 2005;11(8):963–72.PubMedGoogle Scholar
  59. 59.
    Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300(20):2379–88.PubMedGoogle Scholar
  60. 60.
    Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–16.PubMedGoogle Scholar
  61. 61.
    Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10(2):417–23.PubMedGoogle Scholar
  62. 62.
    Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158–64.PubMedGoogle Scholar
  63. 63.
    Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest. 2002;122(2):429–36.PubMedGoogle Scholar
  64. 64.
    Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD. 2007;4(1):29–39.PubMedGoogle Scholar
  65. 65.
    Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131(1):20–8.PubMedGoogle Scholar
  66. 66.
    Jennings JH, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009;187(2):128–35.PubMedGoogle Scholar
  67. 67.
    Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15(12):1090–6.PubMedGoogle Scholar
  68. 68.
    Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–9.PubMedGoogle Scholar
  69. 69.
    Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11(2):188–95.PubMedGoogle Scholar
  70. 70.
    Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009;71(6):667–74.PubMedGoogle Scholar
  71. 71.
    Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216–26.PubMedGoogle Scholar
  72. 72.
    Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.PubMedGoogle Scholar
  73. 73.
    Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14(1):88–90.PubMedGoogle Scholar
  74. 74.
    Nguyen HQ, Carrieri-Kohlman V. Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood. Psychosomatics. 2005;46(5):402–10.PubMedGoogle Scholar
  75. 75.
    Jerant A, Kravitz R, Moore-Hill M, Franks P. Depressive symptoms moderated the effect of chronic illness self-management training on self-efficacy. Med Care. 2008;46(5):523–31.PubMedGoogle Scholar
  76. 76.
    Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther. 1992;30(1):75–7.PubMedGoogle Scholar
  77. 77.
    Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007;132(1):148–55.PubMedGoogle Scholar
  78. 78.
    Livermore N, Butler JE, Sharpe L, McBain RA, Gandevia SC, McKenzie DK. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(1):7–12.PubMedGoogle Scholar
  79. 79.
    Giardino ND, Curtis JL, Abelson JL, et al. The impact of panic disorder on interoception and dyspnea reports in chronic obstructive pulmonary disease. Biol Psychol. 2010;84(1):142–6.PubMedGoogle Scholar
  80. 80.
    Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374–83.PubMedGoogle Scholar
  81. 81.
    Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–41.PubMedGoogle Scholar
  82. 82.
    Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry. 2004;56(11):819–24.PubMedGoogle Scholar
  83. 83.
    Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol. 2004;500(1–3):399–411.PubMedGoogle Scholar
  84. 84.
    Taylor JL, Grossberg SE. The effects of interferon-alpha on the production and action of other cytokines. Semin Oncol. 1998;25(1 Suppl 1):23–9.PubMedGoogle Scholar
  85. 85.
    Capuron L, Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient’s initial affective state. N Engl J Med. 1999;340(17):1370.PubMedGoogle Scholar
  86. 86.
    Booij L, Van der Does W, Benkelfat C, et al. Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology. 2002;27(5):852–61.PubMedGoogle Scholar
  87. 87.
    Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry. 2003;160(7):1342–5.PubMedGoogle Scholar
  88. 88.
    O’Brien SM, Scott LV, Dinan TG. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 2006;188:449–52.PubMedGoogle Scholar
  89. 89.
    Sutcigil L, Oktenli C, Musabak U, et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2007;2007:76396.PubMedGoogle Scholar
  90. 90.
    Taler M, Gil-Ad I, Lomnitski L, et al. Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol. 2007;17(12):774–80.PubMedGoogle Scholar
  91. 91.
    O’Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res. 2007;41(3–4):326–31.PubMedGoogle Scholar
  92. 92.
    Bremmer MA, Beekman AT, Deeg DJ, et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249–55.PubMedGoogle Scholar
  93. 93.
    Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003;65(3):347–56.PubMedGoogle Scholar
  94. 94.
    Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010–4.PubMedGoogle Scholar
  95. 95.
    Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004;161(2):271–7.PubMedGoogle Scholar
  96. 96.
    Miller GE, Freedland KE, Carney RM. Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. J Psychosom Res. 2005;59(4):231–6.PubMedGoogle Scholar
  97. 97.
    Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry. 2007;62(4):314–20.PubMedGoogle Scholar
  98. 98.
    Arbelaez JJ, Ariyo AA, Crum RM, Fried LP, Ford DE. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J Am Geriatr Soc. 2007;55(11):1825–30.PubMedGoogle Scholar
  99. 99.
    Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39(3):413–23.PubMedGoogle Scholar
  100. 100.
    Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60.PubMedGoogle Scholar
  101. 101.
    Dalar L. Relation between depression and anxiety and inflammatory markers in stable COPD cases. Am J Respir Crit Care Med. 2008;177(Abstracts Issue):A826.Google Scholar
  102. 102.
    Incalzi RA, Chiappini F, Fuso L, Torrice MP, Gemma A, Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med. 1998;92(3):527–33.PubMedGoogle Scholar
  103. 103.
    Incalzi RA, Bellia V, Maggi S, et al. Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction. Aging Clin Exp Res. 2002;14(5):395–401.Google Scholar
  104. 104.
    Moore MC, Zebb BJ. The catastrophic misinterpretation of physiological distress. Behav Res Ther. 1999;37(11):1105–18.PubMedGoogle Scholar
  105. 105.
    Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry. 1990;147(2):200–1.PubMedGoogle Scholar
  106. 106.
    Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701–9.PubMedGoogle Scholar
  107. 107.
    Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297(4):367–79.PubMedGoogle Scholar
  108. 108.
    Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289(23):3106–16.PubMedGoogle Scholar
  109. 109.
    Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration. 1993;60(4):216–20.PubMedGoogle Scholar
  110. 110.
    de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2003;84(8):1154–7.PubMedGoogle Scholar
  111. 111.
    Kunik ME, Veazey C, Cully JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008;38(3):385–96.PubMedGoogle Scholar
  112. 112.
    Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104(7):986–94.PubMedGoogle Scholar
  113. 113.
    Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur Respir J. 2010;35(3):557–63.PubMedGoogle Scholar
  114. 114.
    Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol. 2008;13(Pt 3):381–400.PubMedGoogle Scholar
  115. 115.
    Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.PubMedGoogle Scholar
  116. 116.
    Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17(3):232–40.PubMedGoogle Scholar
  117. 117.
    Guell R, Resqueti V, Sangenis M, et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest. 2006;129(4):899–904.PubMedGoogle Scholar
  118. 118.
    Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86(1):30–6.PubMedGoogle Scholar
  119. 119.
    Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–8.PubMedGoogle Scholar
  120. 120.
    Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res. 2007;63(5):551–65.PubMedGoogle Scholar
  121. 121.
    Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2001;16(5):451–4.PubMedGoogle Scholar
  122. 122.
    Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010;71(Suppl E1):e04.PubMedGoogle Scholar
  123. 123.
    Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008;22(4):343–96.PubMedGoogle Scholar
  124. 124.
    Pilling S, Anderson I, Goldberg D, Meader N, Taylor C. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009;339:b4108.PubMedGoogle Scholar
  125. 125.
    Pirraglia PA, Charbonneau A, Kader B, Berlowitz DR. Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans. Prim Care Companion J Clin Psychiatry. 2006;8(2):71–6.PubMedGoogle Scholar
  126. 126.
    Jordan N, Lee TA, Valenstein M, Weiss KB. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med. 2007;22(10):1447–52.PubMedGoogle Scholar
  127. 127.
    Jordan N, Lee TA, Valenstein M, Pirraglia PA, Weiss KB. Effect of depression care on outcomes in COPD patients with depression. Chest. 2009;135(3):626–32.PubMedGoogle Scholar
  128. 128.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMedGoogle Scholar
  129. 129.
    Beck AT, Steer RA, Garbin M. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.Google Scholar
  130. 130.
    Beck AT, Steer RA. Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation; 1990.Google Scholar
  131. 131.
    Adshead F, Cody DD, Pitt B. BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ. 1992;305(6850):397.PubMedGoogle Scholar
  132. 132.
    Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.Google Scholar
  133. 133.
    Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84.PubMedGoogle Scholar
  134. 134.
    Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shoter version. In: Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York: The Haworth Press; 1986. p. 165–73.Google Scholar
  135. 135.
    Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med. 1976;6(3):439–49.PubMedGoogle Scholar
  136. 136.
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.PubMedGoogle Scholar
  137. 137.
    Guy W. ECDEU assessment manual of psychopharmacology – revised. Rockville, MD: U.S. Department of Health E, and Welfare; 1976.Google Scholar
  138. 138.
    Kayahan B, Karapolat H, Atyntoprak E, Atasever A, Ozturk O. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med. 2006;100(6):1050–7.PubMedGoogle Scholar
  139. 139.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedGoogle Scholar
  140. 140.
    Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.PubMedGoogle Scholar
  141. 141.
    Snaith RP, Harrop FM, Newby DA, Teale C. Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales. Br J Psychiatry. 1986;148:599–601.PubMedGoogle Scholar
  142. 142.
    Spielberger CE, Goruch RL. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists; 1970.Google Scholar
  143. 143.
    Kvaal K, Ulstein I, Nordhus IH, Engedal K. The Spielberger State-Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients. Int J Geriatr Psychiatry. 2005;20(7):629–34.PubMedGoogle Scholar
  144. 144.
    Derogatis L. The SCL-90-R manual-I. Baltimore, MD: Clinical Psychometrics Research; 1977.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Medicine, VA Puget Sound Health Care SystemUniversity of Washington School of MedicineSeattleUSA
  2. 2.Department of Psychiatry, VA Ann Arbor Healthcare SystemUniversity of MichiganAnn ArborUSA

Personalised recommendations